Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Plan B lifts women's health for Teva: Second-quarter sales of the emergency contraceptive help drive a 3.9 percent increase in Teva Pharmaceuticals' women's health business to $80 million. Teva is in the midst of de-stocking Plan B inventory as Plan B One-Step -- a single-pill version of the two-pill original product -- becomes available in August, the Jerusalem-based firm said July 28 (1"The Tan Sheet" July 20, 2009). During a same-day earnings call, President and CEO Shlomo Yanai said the women's health business "has outstanding prospects for growth" and Teva intends to expand its oral contraceptive offerings